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Calcium metabolism in uremic nephrocalcinosis: Preventive effect of
verapamil. The aim of the present study was to examine calcium
metabolism of the renal cortex in experimental chronic renal failure,
together with morphologic criteria of nephrocalcinosis and to determine
the effect of chronic verapamil administration on these parameters. In
subtotally nephrectomized (SNX) rats 3 weeks after surgery, renal
cortical calcium content increased more than two-fold. 45Ca incorpo-
ration into renal cortical slices in SNX revealed a 35% increase,
associated with a 50% increase in a lanthanum-resistant fraction of 45Ca
uptake. Radiocalcium wash-out curves in this group demonstrated
abnormal retention of the isotope for up to 30 mm of incubation. In
contrast, radiocalcium incorporation and wash-out in SNX rats chroni-
cally treated with verapamil were similar to that obtained in the sham
group. Verapamil administration significantly reduced, but did not
normalize, renal cortical calcium content. Von Kossa staining demon-
strated the deposition of calcium in the renal parenchyma of SNX rats.
Ultrastructurally, it was accompanied by mitochondrial disorganization
and calcification, as well as by the tubular basement membrane destruc-
tion and mineralization. These morphologic patterns of nephrocalcino-
sis were significantly ameliorated in SNX rats treated with verapamil.
We conclude that chronic verapami! administration results in ameliora-
tion of uremic nephrocalcinosis.
Mtabolisme du calcium au cours de Ia néphro-calcinose urémique:
effet préventif du vérapamil. Le but de cette étude a été d'examiner le
métabolisme calcique du cortex renal au cours d'une insuffisance rénale
chronique expérimentale en méme temps que les critéres
morphologiques de nCphrocalcinose, et de determiner l'effet de
l'administration chronique de vérapamil sur ces paramCtres. Chez des
rats nephrectomises partiellement (SNX), 3 semaines aprCs Ia chirurgie
le contenu en calcium de Ia corticale rénale augmentait plus de deux
fois. L'incorporation de 45Ca aux coupes de corticale rénale chez les
SNX révélait une augmentation de 35%, associée a une élévation de
50% de Ia fraction lanthanum-résistante de Ia captation de 45Ca. Les
courbes de disparition du radiocalcium dans cc groupe démontraient
une retention anormale de l'isotope jusqu'à 30 mm d'incubation. A
l'opposé, l'incorporation et Ia disparition du radiocalcium chez les rats
SNX traités chroniquement au vérapamil étaient identiques a celles
obtenues dans Ic groupe simulacre. L'administration de verapamil a
réduit significativement, mais n'a pas normalisé le contenu cortical
renal en calcium. Une coloration de Von Kossa a démontré des depOts
de calcium dans Ic parenchyme renal des rats SNX. Ultrastructuralle-
ment, cela a été accompagné d'une desorganisation et de calcifications
mitochondriales, et par une destruction et une minéralisation de Ia
membrane basale tubulaire. Ces aspects morphologiques de
nCphrocalcinose Ctaient significativement amCliorCs chez les rats SNX
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traités au vérapamil. Nous concluons que l'administration chronique de
vérapamil améliore la néphrolcalcinose urémique.
Uremic nephrocalcinosis, although a common complication
of chronic renal failure, remains an enigma [1—4]. Since
parathyroidectomy almost completely prevents the develop-
ment of uremic nephrocalcinosis, it has been suggested that
secondary hyperparathyroidism may play an important role in
its pathogenesis [51.
The in vitro effect of parathyroid hormone (PTH) was studied
by Bone [6] and Bone and Uchikawa [7], who demonstrated
that the addition of PTH to the incubation medium led to an
almost three-fold increase in 45Ca incorporation into renal
cortical cells. This enhanced calcium incorporation was attenu-
ated significantly following exclusion of phosphate and magne-
sium from the incubation medium; however, calcium incorpo-
ration still remained elevated. In chronic experiments on rats
with the phosphate-induced secondary hyperparathyroidism,
Borle and Clark [8] demonstrated a marked stimulation of renal
cell calcium metabolism. It was shown that secondary hyper-
parathyroidism caused an intracellular accumulation of cal-
cium, consequently leading to nephrocalcinosis.
Since intracellular calcium accumulation plays a pivotal role
in the expression of PTH-induced nephrocalcinosis, it follows
that attenuation of intracellular calcium influx would be ex-
pected to be of value in ameliorating this effect of PTH.
Recently, calcium channel blockers have been shown to
inhibit various specific effects of PTH on erythrocytes and
cultured myocardial cells [9—11]. Furthermore, attenuation of
calcium influx by verapamil has been demonstrated in the
various epithelial layers as well as in the renal brush border
membrane preparation [12—14]. Thus, it might be suggested thai
the calcium channel blockers may prevent or attenuate uremic
nephrocalcinosis. The aim of the present study was to examine
the renal calcium content, morphologic criteria of nephrocalci-
nosis, and calcium kinetics in mild chronic renal insufficiency
during verapamil treatment. We found that nephrocalcinosis in
mildly uremic rats is associated with an increased calciuni
accumulation, severe mitochondrial disorganization, and min-
eralization of the tubular basement membrane. Chronic
verapamil administration to otherwise identical animals re-
sulted in an almost complete prevention of nephrocalcinosis.
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Methods
Studies were performed on male Charles River rats weighing
250 to 300 g. Animals were fed with regular rat laboratory chow
and allowed water ad lib. Experimental animals were subjected
to 5/6 nephrectomy (SNX) performed via flank incisions in two
steps separated by 1 week, and using intraperitoneal pentobar-
bital anesthesia. Another group of identical rats underwent
sham operation consisting of flank incisions and kidney
decapsulation. All animals were allowed 4 to 5 days to recover
from surgery and then SNX and sham-operated rats were
randomized into four groups: (1) 10 SNX rats treated for 3
weeks by verapamil, 10 tg/l00 g body weight twice a day,
administered intramuscularly (SNX+V); (2) 9 SNX rats receiv-
ing intramuscular injections of 0.9% sodium chloride, 0.1 ml
twice a day for 3 weeks (SNX); (3) 9 sham-operated rats treated
identically to the SNX+V group (C+V); (4) 11 sham-operated
rats treated for 3 weeks with the saline injections, as in group 2
(C).
At the end of the 3-week period, animals were slightly
anesthetized with ether and sacrificed by exsanguination. Blood
samples were analyzed for plasma concentration of creatinine,
BUN, calcium, and inorganic phosphorus. Following sacrifice,
the kidney remnants were removed immediately, and scarred
tissue was excised carefully. The renal cortex was sectioned
and used for the following studies: (1) hematoxylin-eosin and
Von Kossa staining for light microscopic examination to ensure
the completeness of removal of scarred parenchyma and to
verify the presence of nephrocalcinosis; (2) electron micros-
copy and x-ray microprobe analysis; (3) determination of tissue
calcium content and (4) 45Ca uptake and wash-out study.
Metabolic study
Another 20 rats (five in each group) were placed into meta-
bolic cages for 3 weeks and their daily food intake was studied.
Weight gain was examined on a weekly basis. After 1 week on
an unrestricted diet sham-operated animals were pairfed with
SNX rats. The metabolic study was continued for an additional
2 weeks.
Electron microscopy
Renal cortical samples were fixed with 2% glutaraldehyde in
cocadylate buffer, and then transferred to osmium tetroxide
fixative. After dehydration in ethanol, samples were embedded
in araldite 502. Sections (0.8 ) were cut with an ultramicro-
tome (LKB-III, Sweden) and stained with uranyl-citrate and
lead citrate. Preparations were examined by means of transmis-
sion electron microscopy (Philips 201, Holland) and with energy
dispersive x-ray microanalysis on a STEM Jeol 120 XC with ED
spectrum analyzer (Proxan, Elscint, Israel). Preparations were
tilted to 45°; an acceleration voltage of 80 kv was used. In the
preliminary experiments, stained 0.8-p and unstained 2- sec-
tions were examined, and no significant difference in the
sensitivity of detection of calcium in stained and unstained
sections was found. Because of the obvious resolutional advan-
tages in studying stained sections, we subsequently used this
kind of preparation for x-ray microprobe analysis. For this
reason, the elemental spectrum of the stained sections also
contained osmium and lead peaks.
45Ca uptake
Renal cortical slices, each weighing approximately 100 mg,
were preincubated in a metabolic shaker (Dubnoff) for 60 mm at
37°C in oxygenated Krebs-Henseleit solution buffered with 5
mM Hepes, pH 7.4. Calcium uptake and wash-out was studied
according to the slightly modified technique of Uchikawa and
BorIc [151. Briefly, following the equilibration period, slices
were placed in plastic tubes containing 10 ml of the above
medium and 45Ca, 2 CiIml, was added. After the 60-mm
incubation period, slices were removed rapidly for uptake
study. Slices were placed over a Millipore 0.45 p. filter and
rinsed at 4°C twice with 5 ml 45Ca-free buffer. Slices were then
dry-weighed and digested with 5 ml Aquasol. The 45Ca uptake
was measured in a scintillation counter (Packard Instruments,
Downers Grove, Illinois, USA).
In a separate series of experiments, a Lanthanum (La)-
resistant fraction of calcium uptake was studied, according to
the slightly modified technique of Godfraind [161. Following a
60-mm incubation period with radiocalcium (as previously
described), incubation medium was replaced rapidly by Krebs-
Henseleit buffer supplemented with 30 mivi LaCI3. After an
additional 5-mm incubation, the reaction was stopped by filtra-
tion; slices were dry-weighed and digested, and radioactivity
was counted in the same fashion as in the 45Ca uptake series.
45Ca wash-out
Similarly preloaded with 45Ca, slices were incubated in 10 ml
of Krebs-Henseleit solution free of 45Ca for an additional 60 mm
at 37°C. The incubation medium was exchanged every 5 mm. At
2, 5, 10, 30, and 60 mm, samples were removed quickly, rinsed
twice over a Millipore filter, dry-weighed, and digested with
Aquasol. Radioactivity was measured by a scintillation counter
(Packard Instruments). In each experiment, five slices were
used at each point. Results were expressed as counts per
minute per milligram of dry weight.
Calcium content of the renal cortex
The renal cortex was weighed and dried for 24 hr in an oven
at 105°C. Reweighed tissue was hydrolyzed with 0.5 ml of
concentrated hydrochloric acid. The residue was then neutral-
ized with sodium hydroxide solution to pH 7.0, and lanthanum
chloride was added to each sample to a final concentration of
1%. Calcium concentration was determined by atomic absorp-
tion spectrophotometry.
Statistical comparisons between the groups were performed
by means of the Student's non-paired t test. Radiocalcium
wash-out curves were obtained by least square fitting with the
aid of MINIPACK-l code [17].
Results
By 3 weeks after surgery, experimental animals were in
stable renal insufficiency with creatinine and BUN plasma
concentrations of 1.3 0.3 mg% versus 1.2 0.3 mg% and 48
5 mg% versus 46 4 in SNX animals and SNX treated with
verapamil (SNX+V), respectively. In control animals of groups
3 and 4, creatinine and BUN levels were 0.5 0.1 mg% versus
0.5 0.15 mg% and 18 3 mg% versus 19 4 mg%,
respectively. No significant alterations in calcium and inorganic
phosphorus plasma concentration were detected in SNX and
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SNX±V rats (9.6 0.6 and 8.4 0.4 mg% versus 9.4 0.5 and
8.6 0.5 mg%), as compared to control and control+V animals
(9.8 0.4 and 8.2 0.3 mg% versus 9.7 0.6 and 8,2 0.5
mg%).
Food consumption in sham-operated animals on the liberal
diet averaged 24 2 glday, resulting in a weight gain of 40.3
3.7 glweek. In SNX and SNX+V rats daily food intake was 18
1.6 and 19 2 g of rat chow, respectively. Weekly weight
gain in both groups was also similar, averaging 12.6 2.8 and
13.1 1.5 g. Sham-operated animals pairfed with SNX rats
revealed a weekly weight gain of 13 2 g: the value was not
statistically different from both experimental groups. Hence,
verapamil-treated and untreated SNX rats were similar in terms
of their blood chemistry and protein and caloric intake. Thus,
these mildly azotemic animals offer a convenient model to study
the effect of chronic verapamil administration, unrelated to
changes in the plasma level of BUN, creatinine, calcium and
phosphorus, and in the metabolic state.
In Figure 1A, renal cortical calcium content in the four
experimental groups is depicted. The average calcium content
in SNX rats was 32.3 5.8 mmoles/kg dry weight, a value
considerably higher (P < 0.001) than 14.0 2.6 mmoles/kg dry
weight and 12.5 2.5 mmoles/kg dry weight seen in sham-
operated untreated and verapamil-treated animals, respec-
tively. In verapamil-treated SNX rats, renal cortical calcium
content (21.3 4.4 mmoles/kg dry weight) was significantly
lower (P <0.001) than that seen in SNX rats, but still higher (P
<0.001) than control values.
45Ca incorporation into kidney cortical slices from SNX rats
(Fig. 1B) revealed a 35% increase (P < 0.05) as compared to
control values, as well as a substantial elevation (30%), com-
pared to SNX animals treated with chronic verapamil adminis-
tration (P < 0.05). La-resistant fraction of radiocalcium uptake
exhibited even more profound differences between control and
SNX animals. 45Ca incorporation into La-treated renal cortical
slices from SNX rats revealed a 50% increase (P < 0.001),
compared to similarly treated slices in the sham group. This
data indicates that the increase in 45Ca incorporation into slices
Fig. 2A. Von Kossa staining of kidney section obtained from SNX rat.
(Magnification x400) B Von Kossa staining of kidney section from SNX
rat treated with verapamil. (Magnification X400)
from SNX rats is due to intracellular accumulation of radi-
ocalcium. It is noteworthy that 45Ca incorporation into renal
cortical slices from SNX+V animals was similar to that ob-
tained in control animals of both verapamil-treated and un-
treated groups. Radiocalcium wash-out curves obtained from
both control groups and verapamil-treated SNX animals were
identical (Fig. lC). In the SNX group, the radioactivity of slices
remained elevated (P < 0.05) as compared to sham and
SNX+V groups up to 30 mm of incubation.
Von Kossa-stained sections of kidney remnants obtained
from SNX rats showed a delicate punctate calcification of renal
tubular cells in the region of the tubular basement membrane
(Fig. 2A). In contrast, calcification was demonstrated to an
obviously lesser extent in sections of verapamil-treated SNX
animals (Fig. 2B).
Ultrastructurally, there is an obvious swelling and disorgani-
zation of mitochondria in uremic animals both treated and
untreated (Fig. 3). However, the prevalence of disorganized
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Fig. IA. Calcium content of the renal cortex in experimental groups: C, control; C+V, control rats chronically treated with verapamil; SNX,
subtotally nephrectomized rats; SNX+V, subtotally nephrectomized rats treated chronically with verapamil. Vertical bars represent mean SD.
B 45Ca incorporation into renal cortical slices in four experimental groups (designation here and below as in Fig. lA). Dotted bars represent
La-resistant fraction of 45Ca uptake. C 5Ca wash-out curves in four experimental groups (in percent to control postloading values). Every curve
is constructed from five time points of 2, 5, 10, 30, and 60 mm (five slices for each point) by least square fitting.
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Fig. 4. Comparative semiquantitative analysis of mitochondrial dam-
age in verapamil-trea ted and untreated SNX animals. The numbers
represent: 1, percent of intact mitochondria; 2, partially disorganized
mitochondria; 3, percent of mitochondria with completely distorted
internal structure.
prominent. Mitochrondria of SNX rats revealed swelling of
condensed forms, electron density, herniation of internal mem-
brane, destruction of cristae and the complete loss of internal
structure (Fig. 3B). These findings are in obvious contrast to the
relatively intact state of mitochondrial structure in SNX rats
treated with verapamil (Fig. 3C).
To semiquantitate the extent of mitochrondrial disorganiza-
tion in this model of chronic uremia, 500 randomly selected
objects were examined in each group of treated and untreated
animals. Mitochrondrial ultrastructure was arbitrarily subdi-
vided as following: (1) intact mitochondria; (2) partial dis-
organization (destruction of at least one-third of the cristae
and/or herniation of internal membrane); (3) complete destruc-
Fig. 5. X-ray microprobe patterns of background (A), intact
mitochondria (B), and disorganized mitochondria (C). Peaks of osmium
and lead are the result of staining procedures. Note the appearance of
a peak characteristic of calcium in the disorganized mitochondria.
tion of the internal structure. The comparative analysis of
mitochondrial ultrastructure in SNX and SNX+V animals is
depicted in Figure 4. Verapamil treatment is associated with an
increase (P < 0.05) in the fraction of intact mitochondria and a
decrease (P < 0.05) in the subpopulation of completely dis-
torted forms.
The typical x-ray microanalysis patterns of intact and dis-
organized mitochondria are depicted in Figure 5 (B and C,
respectively). The disorganized mitochondria reveal a small but
consistent peak characteristic of calcium (5 C), which com-
prised 7.3 0.5% of the total elemental content. In contrast, in
intact mitochondria calcium content was beyond the lower limit
of detection.
The tubular basement membrane represents another site of
severe structural alteration in SNX rats. As depicted in Figure
6B, the tubular basement membrane in this condition appears
irregular and non-homogenous. X-ray microanalysis of such a
membrane (Fig. 6C2) shows the consistent patterns of calcium,
phosphorus, aluminum, and silicon, indicating that structural
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Fig. 6. Electron micrographs of the tubular basement membrane in SNX+V(A) and SNX (B) rats. Note the loss of homogeneity and integrity of
the tubular basement membrane in the SNX rat, as compared to intact membrane in SNX+V animal. (Magnification x30,000) C represents an x-ray
microprobe analysis of the tubular basement membrane in SNX+V (1) and SNX (2) rats. The latter reveals calcium, phosphorus, aluminum, and
silicon patterns characteristic of linear mineralization of the tubular basement membrane (2). This phenomenon is ameliorated in SNX+V rats (I).
the tubular basement membrane. Chronic verapamil treatment
of SNX rats leads to a structural sparing of the tubular base-
ment membrane (Fig. 6A) and considerably reduced mineraliza-
tion (Fig. 6C1).
Discussion
This study offers good evidence that intracellular calcium
accumulation plays a pivotal role in the pathogenesis of uremic
nephrocalcinosis, and that the calcium channel blocker
verapamil reduces nephrocalcinosis via normalization of cel-
lular calcium metabolism.
Both histology and elevated calcium content of the renal
parenchyma indicate that nephrocalcinosis already occurs in
mildly uremic rats. The radiocalcium study revealed that this
condition is associated with an increased incorporation of the
isotope by the renal cortical slices. Increased La-resistant
fraction of 45Ca uptake in SNX rats further indicates that
intracellular accumulation is responsible for enhanced incorpo-
ration of radiocalcium into renal cortical slices. Ultrastructur-
ally, this is accompanied by mitochondrial disorganization, as
well as irregularity and destruction of the tubular basement
membrane. Disorganized mitochondria retain calcium and the
tubular basement membrane contains mineral deposits in ure-
mic nephrocalcinosis, as revealed by x-ray microprobe.
We have further found that chronic verapamil administration
to similarly azotemic rats was associated with much lesser Von
Kossa staining patterns and reduced calcium content of renal
tissue. Ultrastructural analysis revealed morphologic complete-
ness and normal mineral content of the tubular basement
membrane. Normal radiocalcium kinetics in renal cortical slices
was found in this experimental group. Whether this preventive
effect of verapamil on the development of nephrocalcinosis was
mediated via a direct effect on inward calcium flux, or whether
it was due to verapamil-induced suppression of PTH secretion.
recently demonstrated in vivo [18], we cannot say at this stage.
Much controversy exists at present concerning the possibility
of a direct effect of verapamil on calcium influx in epithelial
cells. Our data, together with others [12—14], does not exclude
such a possibility. However, whatever the precise mechanism
of action of verapamil, the observation that reduced tissue
calcium uptake after verapamil therapy was associated with an
amelioration of nephrocalcinosis indicates that abnormal cel-
lular accumulation of calcium represents an important step in
the pathogenesis of uremic nephrocalcinosis. In this context,
the study of Nayler, Mas-Dliva, and Williams [19] on the
isolated perfused heart is of interest. During low-perfusion
protocol, myocardial cells displayed mitochondrial calcification
which was ameliorated by verapamil. Since PTH was excluded
by the experimental design, in this study at least, verapamil
appeared to have a direct membrane effect. Recent data on
PTH-induced changes in the membrane phospholipid composi-
tion which modulate membrane permeability to calcium [14, 20,
211, may provide the missing link between secondary hyper-
parathyroidism and nephrocalcinosis. In this sequence altera-
tion of the cellular permeability to calcium would occupy the
central role.
This view is supported by evidence from another model of
nephrocalcinosis, namely, that induced by PTH. Secondary
hyperparathyroidism in rats fed a high-phosphate diet was
associated with renal cellular calcium accumulation within 24 hr
[8]. Accumulation of calcium within the mitochondrial compart-
ment was prominent in this model of nephrocalcinosis. Simi-
larly, repeated injections of PTH in mice resulted in nephrocal-
cinosis. Mitochondrial disorganization was detected in the early
stage of the process, even before the appearance of nephrocal-
cinosis [22, 23]. It is of interest that in nephrocalcinosis pro-
duced by vitamin D overdose, mitochondria are also the pri-
mary site of the cellular damage [24]. When 2,4-dinitrophenol
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was inoculated together with vitamin D, the dosage of the latter
required to induce nephrocalcinosis was reduced significantly.
It was thus postulated by Scarpelli [241 that mitochondria exert
a protective effect against nephrocalcinosis, and their oblitera-
tion accelerates the development of renal calcification.
In this context, it is noteworthy that in subtotally nephrecto-
mized rats, the bulk of the mitochondrial population of proximal
tubular epithelial cells showed swelling, disorganization with
the appearance of condensed forms, loss of integrity of the
external membrane, and complete loss of cristae (Figs. 3B and
4). In these disorganized mitochondria calcium is discernible by
means of x-ray microanalysis. This phenomenon has recently
been considered a manifestation of mitochondrial damage [25].
The latter could be a result of ischemia with secondary altera-
tion of a calcium-accumulating capacity [26], or, alternatively,
could be caused by calcium overload [19, 271. In our experi-
mental setting an improvement in the mitochondrial state fol-
lowing chronic verapamil administration might indicate that in
subtotally nephrectomized rats an elevation of intracellular
calcium influx contributes to mitochondrial damage. However,
this remains a speculation at present.
In this study, we did not explore another possible mode of
action of verapamil in chronic uremia, namely, that mediated
via vascular smooth muscle tone. Recently, this mechanism has
been shown essential in prevention of norepinephrine-induced
acute renal failure [28]. We have shown [29] that chronic
verapamil administration to SNX rats resulted in an ameliora-
tion of arterial hypertension. It is hitherto unclear what impact
this may have on the extent of uremic nephrocalcinosis. It is of
interest that renal calcium content in patients with arterial
hypertension is elevated [30]. The relationship between hyper-
tension and nephrocalcinosis remains to be established.
In summary, we have shown that uremic nephrocalcinosis is
associated with renal cortical accumulation of calcium and
mitochondrial calcification and damage. These phenomena
were ameliorated by chronic verapamil administration, together
with a correction of the abnormal calcium influx. We suggest
that the basic alteration in uremia, which results in nephrocal-
cinosis, is an increase in cellular calcium influx.
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